772490008: Product containing glycopyrronium and neostigmine in parenteral dose form (medicinal product form)

• SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quaternary ammonium compound (product)\Glycopyrronium-containing product\...
• \Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Product manufactured as parenteral dose form (product)\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Product manufactured as parenteral dose form (product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Product containing autonomic agent (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form
• \Product containing autonomic agent (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3718542017	Glycopyrronium- and neostigmine-containing product in parenteral dose form	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3718543010	Product containing glycopyrronium and neostigmine in parenteral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5529501000241110	produit contenant du glycopyrronium et de la néostigmine sous forme parentérale	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

This concept is not in any reference sets

Back to Start